Tags

Type your tag names separated by a space and hit enter

Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases.
Adv Med Sci. 2006; 51:250-3.AM

Abstract

PURPOSE

The aim of the study was to assess the incidence of Ureaplasma urealyticum (U. urealyticum) and Mycoplasma hominis (M. hominis) infection in women with urogenital diseases.

MATERIAL AND METHODS

M. hominis and U. urealyticum was assessed in 541 women from gynaecological and STD outpatient clinics, aged 18-55 years. A Mycoplasma IST 2 kit was used for biochemical determination of mycoplasmal infections (BioMerieux). Additionally, 248 of patients were examined for Chlamydia trachomatis (C. trachomatis), Trichomonas vaginalis (T. vaginalis) and Candida albicans (C. albicans) infection. C. trachomatis was detected by direct immunofluorescence method. The standard culture methods (Biomed) were applied to detect T. vaginalis and C. albicans.

RESULTS

U. urealyticum was detected in 161 (29.8%), and M. hominis in 20 (3.7%) women. U. urealyticum infection alone was observed in 37/79 (46.8%), and 1/8 (12.5%) patient had only M. hominis infection. The U. urealyticum infection showed most frequent coexistence with C. albicans (29.1%), and less frequent with C. trachomatis (13.9%) and M. hominis infection (10.1%). The highest percentage of mycoplasma-positive cultures was found in patients of STD clinic and in infertile women. In patients with ureaplasmal infection only the most common clinical symptom was vaginal discharge and vulval/vaginal irritation. In 8.1% of the women, the course of U urealyticum infection was asymptomatic.

CONCLUSIONS

The incidence rate of genitourinary infections due to U urealyticum was significantly higher as compared to M. hominis infection. Sexual mycoplasmal infections were most frequently reported in the group of patients of STD clinic and correlated with age and sexual activity.

Authors+Show Affiliations

Department of Dermatology and Venerology, Medical University of Białystok, Poland.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17357319

Citation

Zdrodowska-Stefanow, B, et al. "Ureaplasma Urealyticum and Mycoplasma Hominis Infection in Women With Urogenital Diseases." Advances in Medical Sciences, vol. 51, 2006, pp. 250-3.
Zdrodowska-Stefanow B, Kłosowska WM, Ostaszewska-Puchalska I, et al. Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Adv Med Sci. 2006;51:250-3.
Zdrodowska-Stefanow, B., Kłosowska, W. M., Ostaszewska-Puchalska, I., Bułhak-Kozioł, V., & Kotowicz, B. (2006). Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Advances in Medical Sciences, 51, 250-3.
Zdrodowska-Stefanow B, et al. Ureaplasma Urealyticum and Mycoplasma Hominis Infection in Women With Urogenital Diseases. Adv Med Sci. 2006;51:250-3. PubMed PMID: 17357319.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. AU - Zdrodowska-Stefanow,B, AU - Kłosowska,W M, AU - Ostaszewska-Puchalska,I, AU - Bułhak-Kozioł,V, AU - Kotowicz,B, PY - 2007/3/16/pubmed PY - 2007/7/6/medline PY - 2007/3/16/entrez SP - 250 EP - 3 JF - Advances in medical sciences JO - Adv Med Sci VL - 51 N2 - PURPOSE: The aim of the study was to assess the incidence of Ureaplasma urealyticum (U. urealyticum) and Mycoplasma hominis (M. hominis) infection in women with urogenital diseases. MATERIAL AND METHODS: M. hominis and U. urealyticum was assessed in 541 women from gynaecological and STD outpatient clinics, aged 18-55 years. A Mycoplasma IST 2 kit was used for biochemical determination of mycoplasmal infections (BioMerieux). Additionally, 248 of patients were examined for Chlamydia trachomatis (C. trachomatis), Trichomonas vaginalis (T. vaginalis) and Candida albicans (C. albicans) infection. C. trachomatis was detected by direct immunofluorescence method. The standard culture methods (Biomed) were applied to detect T. vaginalis and C. albicans. RESULTS: U. urealyticum was detected in 161 (29.8%), and M. hominis in 20 (3.7%) women. U. urealyticum infection alone was observed in 37/79 (46.8%), and 1/8 (12.5%) patient had only M. hominis infection. The U. urealyticum infection showed most frequent coexistence with C. albicans (29.1%), and less frequent with C. trachomatis (13.9%) and M. hominis infection (10.1%). The highest percentage of mycoplasma-positive cultures was found in patients of STD clinic and in infertile women. In patients with ureaplasmal infection only the most common clinical symptom was vaginal discharge and vulval/vaginal irritation. In 8.1% of the women, the course of U urealyticum infection was asymptomatic. CONCLUSIONS: The incidence rate of genitourinary infections due to U urealyticum was significantly higher as compared to M. hominis infection. Sexual mycoplasmal infections were most frequently reported in the group of patients of STD clinic and correlated with age and sexual activity. SN - 1896-1126 UR - https://www.unboundmedicine.com/medline/citation/17357319/Ureaplasma_urealyticum_and_Mycoplasma_hominis_infection_in_women_with_urogenital_diseases_ L2 - https://www.lens.org/lens/search?q=citation_id:17357319 DB - PRIME DP - Unbound Medicine ER -